Pharmaceutical Technology on MSN3d
Leveragen and Moonlight Bio unite for T-cell therapy development
Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...
pharmaphorum6d
Mustang Bio’s first-of-a-kind CAR-T starts trials
Mustang’s cancer-targeted CAR-T’s include MB-102, a CD123-targeting therapy for acute myelogenous leukaemia that is also partnered with City of Hope and due to start trials shortly, and MB-106 ...